1. Home
  2. LODE vs KRRO Comparison

LODE vs KRRO Comparison

Compare LODE & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$3.44

Market Cap

211.8M

Sector

Industrials

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.29

Market Cap

187.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LODE
KRRO
Founded
1999
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
187.9M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
LODE
KRRO
Price
$3.44
$13.29
Analyst Decision
Hold
Buy
Analyst Count
2
12
Target Price
$4.00
$34.80
AVG Volume (30 Days)
1.4M
128.3K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
N/A
EPS
N/A
N/A
Revenue
$1,553,796.00
$6,392,000.00
Revenue This Year
$1,582.85
N/A
Revenue Next Year
$246.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$2.24
$5.20
52 Week High
$4.98
$55.89

Technical Indicators

Market Signals
Indicator
LODE
KRRO
Relative Strength Index (RSI) 49.36 60.71
Support Level $3.02 $9.76
Resistance Level $3.68 $14.53
Average True Range (ATR) 0.22 0.78
MACD 0.07 0.32
Stochastic Oscillator 78.22 83.25

Price Performance

Historical Comparison
LODE
KRRO

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: